benzeneboronic acid has been researched along with Dry Eye Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J; Liu, D; Pan, W; Song, Y; Tan, G; Yu, Y | 1 |
| Ahmad, A; Boyd, S; Chang, CN; Dozois, MD; Gu, FX; Hileeto, D; Jones, LW; Liang, H; Liu, S; Ng, DL; Reyad, MM | 1 |
2 other study(ies) available for benzeneboronic acid and Dry Eye Syndromes
| Article | Year |
|---|---|
Phenylboronic acid-tethered chondroitin sulfate-based mucoadhesive nanostructured lipid carriers for the treatment of dry eye syndrome.
Topics: Animals; Boronic Acids; Chondroitin Sulfates; Cornea; Dexamethasone; Drug Carriers; Drug Delivery Systems; Dry Eye Syndromes; Eye; Lipids; Mucins; Nanostructures; Ophthalmic Solutions; Particle Size; Powders; Rabbits; Rhodamines; Sialic Acids; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2019 |
Prolonged Ocular Retention of Mucoadhesive Nanoparticle Eye Drop Formulation Enables Treatment of Eye Diseases Using Significantly Reduced Dosage.
Topics: Animals; Boronic Acids; Cyclosporine; Dry Eye Syndromes; Eye Diseases; Female; Male; Mice; Mice, Inbred C57BL; N-Acetylneuraminic Acid; Nanoparticles; Ophthalmic Solutions; Rabbits | 2016 |